Market Overview:
The global hemostasis products market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of bleeding disorders, rising awareness about hemostasis products, and technological advancements in the field of hemostasis products. The global hemostasis products market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into topical hemostasis, infusible hemostasis, and advanced hemostasis. The topical hemostatis segment dominates the global market owing to its easy availability and low cost as compared to other types of hemstosis products. On th ebasis o fapplication , t h e m arket i s se gmente d into hospitals an d clinics . Hospitals account for a major share o f t h e globa l h emostasi s prod u cts ma r ket due t o increasin g inciden ce o f bleedin g disorde rs an d advanc ed trea tment options available with hemstosis prod u cts .
Product Definition:
Hemostasis products are used to stop bleeding. They can be used in a variety of ways, including topically, orally, or injected into the blood stream.
Topical Hemostasis:
Topical hemostasis is the process of regulation of blood loss from a wound by applying pressure to it. It's also known as coagulation and occurs naturally during childbirth. Topical hemostasis is used in various conditions such as diabetic foot ulcers, venous leg ulcers, arterial ulcers, surgical wounds and burn injuries.
Infusible Hemostasis:
Infusible hemostasis is a process in which the body's immune system attempts to resolve an abnormal flow of blood. The normal hemostatic mechanism gets triggered when there is a cut or injury to the skin. In case of injuries, the platelets plug the wound and prevent further bleeding; this process is called hemostasis. However, sometimes this mechanism fails and wounds continue to hemorrhage due to lack of clot formation; in such cases, external devices are used for treatment.
Application Insights:
Based on the application, the global hemostasis products market is segmented into hospitals and clinics. Hospitals held the largest share in 2017 owing to a large number of procedures that require blood vessel closure such as surgery for cardiac or peripheral vascular diseases. In addition, rising cases of trauma and burns across the globe also boost product demand in this segment.
Clinics are expected to be fastest growing application over forecast period due to increasing awareness about availability of affordable healthcare services especially in developing countries like India and China. Rising geriatric population prone to various diseases including hypertension, atrial fibrillation etc.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of well-established healthcare infrastructure, high patient awareness levels coupled with relatively higher healthcare expenditure levels in this region. Moreover, increasing prevalence of various disorders such as cancer and diabetes is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to rising geriatric population base and growing prevalence of chronic diseases such as cardiovascular diseases (CVDs), infectious & inflammatory diseases (AIDS), cancers, etc. In addition, improving economic conditions are likely to contribute toward regional growth over next eight years.
Growth Factors:
- Increasing incidence of bleeding disorders such as hemophilia and Von Willebrand disease
- Growing demand for hemostasis products in surgery and trauma care
- Rising awareness about the benefits of early intervention for bleeding disorders
- Technological advancements in hemostasis products industry
- Growing number of mergers and acquisitions among hemostasis product manufacturers
Scope Of The Report
Report Attributes
Report Details
Report Title
Hemostasis Products Market Research Report
By Type
Topical Hemostasis, Infusible Hemostasis, Advanced Hemostasis
By Application
Hospitals, Clinics
By Companies
Integra LifeSciences Corporation, C. R. Bard, Inc., Abbott Laboratories, Takeda International, CSL Behring, HemCon Medical Technologies, Grifols, Johnson & Johnson, Medtronic, Pfizer, Integra LifeSciences Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Hemostasis Products Market Report Segments:
The global Hemostasis Products market is segmented on the basis of:
Types
Topical Hemostasis, Infusible Hemostasis, Advanced Hemostasis
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Integra LifeSciences Corporation
- C. R. Bard, Inc.
- Abbott Laboratories
- Takeda International
- CSL Behring
- HemCon Medical Technologies
- Grifols
- Johnson & Johnson
- Medtronic
- Pfizer
- Integra LifeSciences Corporation
Highlights of The Hemostasis Products Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Topical Hemostasis
- Infusible Hemostasis
- Advanced Hemostasis
- By Application:
- Hospitals
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hemostasis Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hemostasis products are medications that help to prevent or stop bleeding.
Some of the major companies in the hemostasis products market are Integra LifeSciences Corporation, C. R. Bard, Inc., Abbott Laboratories, Takeda International, CSL Behring, HemCon Medical Technologies, Grifols, Johnson & Johnson, Medtronic, Pfizer, Integra LifeSciences Corporation.
The hemostasis products market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hemostasis Products Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hemostasis Products Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hemostasis Products Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hemostasis Products Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hemostasis Products Market Size & Forecast, 2020-2028
4.5.1 Hemostasis Products Market Size and Y-o-Y Growth
4.5.2 Hemostasis Products Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Topical Hemostasis
5.2.2 Infusible Hemostasis
5.2.3 Advanced Hemostasis
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hemostasis Products Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hemostasis Products Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Topical Hemostasis
9.6.2 Infusible Hemostasis
9.6.3 Advanced Hemostasis
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Topical Hemostasis
10.6.2 Infusible Hemostasis
10.6.3 Advanced Hemostasis
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Topical Hemostasis
11.6.2 Infusible Hemostasis
11.6.3 Advanced Hemostasis
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Topical Hemostasis
12.6.2 Infusible Hemostasis
12.6.3 Advanced Hemostasis
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Topical Hemostasis
13.6.2 Infusible Hemostasis
13.6.3 Advanced Hemostasis
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hemostasis Products Market: Competitive Dashboard
14.2 Global Hemostasis Products Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Integra LifeSciences Corporation
14.3.2 C. R. Bard, Inc.
14.3.3 Abbott Laboratories
14.3.4 Takeda International
14.3.5 CSL Behring
14.3.6 HemCon Medical Technologies
14.3.7 Grifols
14.3.8 Johnson & Johnson
14.3.9 Medtronic
14.3.10 Pfizer
14.3.11 Integra LifeSciences Corporation
